ArQule Aktie

2,81 $ 0,00% +0,00 $
In Euro: 2,3065 € | 15:38 Uhr Nasdaq | Mehr Kurse »
WKN: 903396
ISIN: US04269E1073
US-Symbol: ARQL
Typ: Aktie

Performance ArQule Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 2,95 $ 3,17 $ 1,74 $ 1,65 $ 1,01 $ 2,12 $
Änderung -4,75% -11,36% +61,49% +70,30% +178,22% +32,55%

Forum zur ArQule Aktie

Nobsy11: ...
17.04.18
" Under the terms of the agreement, ArQule grants Basilea rights to research, develop, manufacture and exclusively commercialize derazantinib worldwide, excluding the People's Republic of China, Taiwan, Hong Kong and Macau. Basilea will make an upfront payment to ...
Abrafax: Phase 1 Ergebnisse ARQ-501 am 29.09.04
26.09.04
Phase 1 results for ARQ-501 will be presented at AACR-​NCI-EORTC meeting in Geneva and at the same time at UBS Global Life Sciences, NY 29.Sep.04 08.00 EST. 05.Oct.04 ArQule's Analyst Day What's Next- Cancer Therapeutics in the 21st Century übrigens: ARQ-501 ...

Analysen

Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

ArQule Aktie & Unternehmen

Branche Pharmazie
Herkunft USA
Website www.arqule.com
Indizes/Listen NASDAQ
Aktienanzahl 71,1 Mio. (Stand: 26.05.17)
Marktkap. 199,9 Mio. $

Dividenden & Splits

03.10.12 Split 1:2 Berlin
02.10.12 Split 1:2 Frankfurt, München, Stuttgart

Ähnliche Aktien

Name
last
change_rel
 
Palatin Technologies, Inc. 0,938 € -2,29%
Cannabis Science 0,052 € -7,14%
Albireo Pharma 25,80 € +3,74%
Gilead Sciences 59,47 € -1,46%
Achieve Life Sciences 1,05 € -1,87%